{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:08:58Z","timestamp":1793711338226,"version":"4.6.1"},"reference-count":58,"publisher":"Japanese Circulation Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2022,8,25]]},"DOI":"10.1253\/circj.cj-21-0848","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T17:08:37Z","timestamp":1636391317000},"page":"1319-1328","source":"Crossref","is-referenced-by-count":166,"title":["Pathophysiology of Coronary Microvascular Dysfunction"],"prefix":"10.1253","volume":"86","author":[{"given":"Filippo","family":"Crea","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS"},{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco A.","family":"Montone","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Neumann FJ, Sechtem U, Banning AP, Bonaros N, Bueno H, Bugiardini R, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. <i>Eur Heart J<\/i> 2020; 41: 407\u2013477.","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ong P, Camici PG, Beltrame JF, Crea F, Shimokawa H, Sechtem U, et al. International standardization of diagnostic criteria for microvascular angina. <i>Int J Cardiol<\/i> 2018; 250: 16\u201320.","DOI":"10.1016\/j.ijcard.2017.08.068"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Crea F, Merz CNB, Beltrame JF, Kaski JC, Ogawa H, Ong P, et al. The parallel tales of microvascular angina and heart failure with preserved ejection fraction: A paradigm shift. <i>Eur Heart J<\/i> 2017; 38: 473\u2013477.","DOI":"10.1093\/eurheartj\/ehw461"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ford TJ, Stanley B, Good R, Rocchiccioli P, McEntegart M, Watkins S, et al. Stratified medical therapy using invasive coronary function testing in angina: The CorMicA trial. <i>J Am Coll Cardiol<\/i> 2018; 72: 2841\u20132855.","DOI":"10.1016\/j.jacc.2018.09.006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Del Buono MG, Montone RA, Camilli M, Carbone S, Narula J, Lavie CJ, et al. Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC State-of-the-Art Review. <i>J Am Coll Cardiol<\/i> 2021; 78: 1352\u20131371.","DOI":"10.1016\/j.jacc.2021.07.042"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Padro T, Manfrini O, Bugiardini R, Canty J, Cenko E, De Luca G, et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on \u201ccoronary microvascular dysfunction in cardiovascular disease\u201d. <i>Cardiovasc Res<\/i> 2020; 116: 741\u2013755.","DOI":"10.1093\/cvr\/cvaa003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kaski JC, Crea F, Gersh BJ, Camici PG. Reappraisal of ischemic heart disease: Fundamental role of coronary microvascular dysfunction in the pathogenesis of angina pectoris. <i>Circulation<\/i> 2018; 138: 1463\u20131480.","DOI":"10.1161\/CIRCULATIONAHA.118.031373"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Camici PG, Crea F. Coronary microvascular dysfunction. <i>N Engl J Med<\/i> 2007; 356: 830\u2013840.","DOI":"10.1056\/NEJMra061889"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Crea F, Camici PG, Merz CNB. Coronary microvascular dysfunction: An update. <i>Eur Heart J<\/i> 2014; 35: 1101\u20131111.","DOI":"10.1093\/eurheartj\/eht513"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. <i>Circ Res<\/i> 2003; 92: e31\u2013e40.","DOI":"10.1161\/01.RES.0000054200.44505.AB"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bugiardini R, Pozzati A, Ottani F, Morgagni GL, Puddu P. Vasotonic angina: A spectrum of ischemic sysdroms involving function abnormalities of the epicardial and microvascular coronary circulation. <i>J Am Coll Cardiol<\/i> 1993; 22: 417\u2013425.","DOI":"10.1016\/0735-1097(93)90045-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Montone RA, Meucci MC, De Vita A, Lanza GA, Niccoli G. Coronary provocative tests in the catheterization laboratory: Pathophysiological bases, methodological considerations and clinical implications. <i>Atherosclerosis<\/i> 2021; 318: 14\u201321.","DOI":"10.1016\/j.atherosclerosis.2020.12.008"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries: The ACOVA study (abnormal coronary vasomotion in patients with stable angina and unobstructed coronary arteries). <i>J Am Coll Cardiol<\/i> 2012; 59: 655\u2013662.","DOI":"10.1016\/j.jacc.2011.11.015"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yun JS, Park YM, Cha SA, Ahn YB, Ko SH. Progression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes. <i>Cardiovasc Diabetol<\/i> 2018; 17: 109.","DOI":"10.1186\/s12933-018-0752-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Masi S, Rizzoni D, Taddei S, Widmer RJ, Montezano AC, L\u00fcscher TF, et al. Assessment and pathophysiology of microvascular disease: Recent progress and clinical implications. <i>Eur Heart J<\/i> 2021; 42: 2590\u20132604.","DOI":"10.1093\/eurheartj\/ehaa857"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Francia P, Delli Gatti C, Bachschmid M, Martin-Padura I, Savoia C, Migliaccio E, et al. Deletion of p66shc gene protects against age-related endothelial dysfunction. <i>Circulation<\/i> 2004; 110: 2889\u20132895.","DOI":"10.1161\/01.CIR.0000147731.24444.4D"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Magenta A, Greco S, Capogrossi MC, Gaetano C, Martelli F. Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction. <i>Biomed Res Int<\/i> 2014; 2014: 193095.","DOI":"10.1155\/2014\/193095"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Suda A, Takahashi J, Hao K, Kikuchi Y, Shindo T, Ikeda S, et al. Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease. <i>J Am Coll Cardiol<\/i> 2019; 74: 2350\u20132360.","DOI":"10.1016\/j.jacc.2019.08.1056"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. <i>Eur Heart J<\/i> 2013; 34: 2436\u20132443.","DOI":"10.1093\/eurheartj\/eht149"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. <i>J Am Coll Cardiol<\/i> 1999; 34: 146\u2013154.","DOI":"10.1016\/S0735-1097(99)00168-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Giacco F, Brownlee M. Oxidative stress and diabetic complications. <i>Circ Res<\/i> 2010; 107: 1058\u20131070.","DOI":"10.1161\/CIRCRESAHA.110.223545"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: Sparking the development of diabetic vascular injury. <i>Circulation<\/i> 2006; 114: 597\u2013605.","DOI":"10.1161\/CIRCULATIONAHA.106.621854"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Gao X, Zhang H, Schmidt AM, Zhang C. AGE\/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic mice. <i>Am J Physiol Heart Circ Physiol<\/i> 2008; 295: H491\u2013H498.","DOI":"10.1152\/ajpheart.00464.2008"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kim JA, Montagnani M, Kwang KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms. <i>Circulation<\/i> 2006; 113: 1888\u20131904.","DOI":"10.1161\/CIRCULATIONAHA.105.563213"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Joshi M, Kotha SR, Malireddy S, Selvaraju V, Satoskar AR, Palesty A, et al. Conundrum of pathogenesis of diabetic cardiomyopathy: Role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria. <i>Mol Cell Biochem<\/i> 2014; 386: 233\u2013249.","DOI":"10.1007\/s11010-013-1861-x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet dysfunction in type 2 diabetes. <i>Diabetes Care<\/i> 2001; 24: 1476\u20131485.","DOI":"10.2337\/diacare.24.8.1476"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Triantafyllou A, Anyfanti P, Triantafyllou G, Zabulis X, Aslanidis S, Douma S. Impaired metabolic profile is a predictor of capillary rarefaction in a population of hypertensive and normotensive individuals. <i>J Am Soc Hypertens<\/i> 2016; 10: 640\u2013646.","DOI":"10.1016\/j.jash.2016.04.007"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Bagi Z, Feher A, Cassuto J, Akula K, Labinskyy N, Kaley G, et al. Increased availability of angiotensin AT 1 receptors leads to sustained arterial constriction to angiotensin II in diabetes: Role for Rho-kinase activation. <i>Br J Pharmacol<\/i> 2011; 163: 1059\u20131068.","DOI":"10.1111\/j.1476-5381.2011.01307.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Alonso R, Mata P, De Andres R, Villacastin BP, Mart\u00ednez-Gonz\u00e1lez J, Badimon L. Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin. <i>Atherosclerosis<\/i> 2001; 157: 423\u2013429.","DOI":"10.1016\/S0021-9150(00)00733-4"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hein TW, Liao JC, Kuo L. oxLDL specifically impairs endothelium-dependent, NO-mediated dilation of coronary arterioles. <i>Am J Physiol Heart Circ Physiol<\/i> 2000; 278: H175\u2013H183.","DOI":"10.1152\/ajpheart.2000.278.1.H175"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Padr\u00f3 T, Vilahur G, Badimon L. Dyslipidemias and microcirculation. <i>Curr Pharm Des<\/i> 2018; 24: 2921\u20132926.","DOI":"10.2174\/1381612824666180702154129"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kachur S, Morera R, De Schutter A, Lavie CJ. Cardiovascular risk in patients with prehypertension and the metabolic syndrome. <i>Curr Hypertens Rep<\/i> 2018; 20: 15.","DOI":"10.1007\/s11906-018-0801-2"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Aziz A, Hansen HS, Sechtem U, Prescott E, Ong P. Sex-related differences in vasomotor function in patients with angina and unobstructed coronary arteries. <i>J Am Coll Cardiol<\/i> 2017; 70: 2349\u20132358.","DOI":"10.1016\/j.jacc.2017.09.016"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Cenko E, van der Schaar M, Yoon J, Kedev S, Valvukis M, Vasiljevic Z, et al. Sex-specific treatment effects after primary percutaneous intervention: A study on coronary blood flow and delay to hospital presentation. <i>J Am Heart Assoc<\/i> 2019; 8: e011190.","DOI":"10.1161\/JAHA.118.011190"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Del Buono MG, Montone RA, Iannaccone G, Meucci MC, Rinaldi R, D\u2019Amario D, et al. Diagnostic work-up and therapeutic implications in MINOCA: Need for a personalized approach. <i>Future Cardiol<\/i> 2021; 17: 149\u2013154.","DOI":"10.2217\/fca-2020-0052"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Montone RA, Niccoli G, Fracassi F, Russo M, Gurgoglione F, Camm\u00e0 G, et al. Patients with acute myocardial infarction and non-obstructive coronary arteries: Safety and prognostic relevance of invasive coronary provocative tests. <i>Eur Heart J<\/i> 2018; 39: 91\u201398.","DOI":"10.1093\/eurheartj\/ehx667"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Galiuto L, De Caterina AR, Porfidia A, Paraggio L, Barchetta S, Locorotondo G, et al. Reversible coronary microvascular dysfunction: A common pathogenetic mechanism in apical ballooning or Tako-Tsubo syndrome. <i>Eur Heart J<\/i> 2010; 31: 1319\u20131327.","DOI":"10.1093\/eurheartj\/ehq039"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Montone RA, Galiuto L, Meucci MC, Del Buono MG, Vergni F, Camilli M, et al. Coronary slow flow is associated with a worse clinical outcome in patients with Takotsubo syndrome. <i>Heart<\/i> 2020; 106: 923\u2013930.","DOI":"10.1136\/heartjnl-2019-315909"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary-artery stenosis. <i>N Engl J Med<\/i> 1994; 330: 1782\u20131788.","DOI":"10.1056\/NEJM199406233302503"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Duncker DJ, Koller A, Merkus D, Canty JM. Regulation of coronary blood flow in health and ischemic heart disease. <i>Prog Cardiovasc Dis<\/i> 2015; 57: 409\u2013422.","DOI":"10.1016\/j.pcad.2014.12.002"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Beyer AM, Zinkevich N, Miller B, Liu Y, Wittenburg AL, Mitchell M, et al. Transition in the mechanism of flow-mediated dilation with aging and development of coronary artery disease. <i>Basic Res Cardiol<\/i> 2017; 112: 5.","DOI":"10.1007\/s00395-016-0594-x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Shimoni S, Frangogiannis NG, Aggeli CJ, Shan K, Quinones MA, Espada R, et al. Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction: Implications for the assessment of myocardial hibernation. <i>Circulation<\/i> 2002; 106: 950\u2013956.","DOI":"10.1161\/01.CIR.0000026395.19594.43"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Niccoli G, Montone RA, Lanza GA, Crea F. Angina after percutaneous coronary intervention: The need for precision medicine. <i>Int J Cardiol<\/i> 2017; 248: 14\u201319.","DOI":"10.1016\/j.ijcard.2017.07.105"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Sechtem U, Brown D, Godo S, Lanza GA, Shimokawa H, Sidik N. Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and obstructive coronary artery disease). <i>Cardiovasc Res<\/i> 2020; 116: 771\u2013786.","DOI":"10.1093\/cvr\/cvaa005"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Niccoli G, Montone RA, Ibanez B, Thiele H, Crea F, Heusch G, et al. Optimized treatment of ST-elevation myocardial infarction: The unmet need to target coronary microvascular obstruction as primary treatment goal to further improve prognosis. <i>Circ Res<\/i> 2019; 125: 245\u2013258.","DOI":"10.1161\/CIRCRESAHA.119.315344"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. \u010culi\u0107 V. Heart failure with preserved ejection fraction. <i>N Engl J Med<\/i> 2017; 376: 896.","DOI":"10.1056\/NEJMc1615918"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Del Buono MG, Iannaccone G, Scacciavillani R, Carbone S, Camilli M, Niccoli G, et al. Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence. <i>Prog Cardiovasc Dis<\/i> 2020; 63: 570\u2013584.","DOI":"10.1016\/j.pcad.2020.04.011"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure overloaded rats. <i>Circulation<\/i> 2002; 106: 130\u2013135.","DOI":"10.1161\/01.CIR.0000020689.12472.E0"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Taqueti VR, Solomon SD, Shah AM, Desai AS, Groarke JD, Osborne MT, et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. <i>Eur Heart J<\/i> 2018; 39: 840\u2013849.","DOI":"10.1093\/eurheartj\/ehx721"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. McConkey HZR, Marber M, Chiribiri A, Pibarot P, Redwood SR, Prendergast BD. Coronary microcirculation in aortic stenosis. <i>Circ Cardiovasc Interv<\/i> 2019; 12: e007547.","DOI":"10.1161\/CIRCINTERVENTIONS.118.007547"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Beyerbacht HP, Lamb HJ, van Der Laarse A, Vliegen HW, Leujes F, Hazekamp MG, et al. Aortic valve replacement in patients with aortic valve stenosis improves myocardial metabolism and diastolic function. <i>Radiology<\/i> 2001; 219: 637\u2013643.","DOI":"10.1148\/radiology.219.3.r01jn25637"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Augusto JB, Johner N, Shah D, Nordin S, Knott KD, Rosmini S, et al. The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage. <i>Eur Heart J Cardiovasc Imaging<\/i> 2021; 22: 790\u2013799.","DOI":"10.1093\/ehjci\/jeaa101"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Dorbala S, Vangala D, Bruyere J, Quarta C, Kruger J, Padera R, et al. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. <i>JACC Heart Fail<\/i> 2014; 2: 358\u2013367.","DOI":"10.1016\/j.jchf.2014.03.009"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Kul S, Kutlu GA, Guvenc TS, Kavas M, Demircioglu K, Yilmaz Y, et al. Coronary flow reserve is reduced in sarcoidosis. <i>Atherosclerosis<\/i> 2017; 264: 115\u2013121.","DOI":"10.1016\/j.atherosclerosis.2017.05.005"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC State-of-the-Art Review. <i>J Am Coll Cardiol<\/i> 2020; 75: 2950\u20132973.","DOI":"10.1016\/j.jacc.2020.04.031"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Montone RA, Iannaccone G, Meucci MC, Gurgoglione F, Niccoli G. Myocardial and microvascular injury due to coronavirus disease 2019. <i>Eur Cardiol<\/i> 2020; 15: e52.","DOI":"10.15420\/ecr.2020.22"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Gahl B, G\u00f6ber V, Odutayo A, Stahel HTT, da Costa BR, Jakob SM, et al. Prognostic value of early postoperative troponin T in patients undergoing coronary artery bypass grafting. <i>J Am Heart Assoc<\/i> 2018; 7: e007743.","DOI":"10.1161\/JAHA.117.007743"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Tona F, Osto E, Famoso G, Previato M, Fedrigo M, Vecchiati A, et al. Coronary microvascular dysfunction correlates with the new onset of cardiac allograft vasculopathy in heart transplant patients with normal coronary angiography. <i>Am J Transplant<\/i> 2015; 15: 1400\u20131466.","DOI":"10.1111\/ajt.13108"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/86\/9\/86_CJ-21-0848\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T01:19:54Z","timestamp":1715217594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/86\/9\/86_CJ-21-0848\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-21-0848","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"article-number":"CJ-21-0848"}}